In response to the release of the updated 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease, authors representing the AATS and STS came together to write a rebuttal explaining their perspective on the controversial guidelines. In an interview with CTSNet Editor in Chief Joel Dunning, revascularization specialist and AATS representative Dr. Faisal Bakaeen elaborates on the surgeons’ perspective.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Coronary Disease
August 8, 2023
August 7, 2023
In a research letter on a small pilot genomic study of sampling coronary atheroma, the authors offer a brief explanation on how their technique can be applied to detect stability of coronary plaque.
July 27, 2023
These new guidelines contain wide-ranging recommendations on the use of beta-blockers, sodium-glucose cotransporter-2 (SGLT2) inhibitors and glucagon-like peptide-1, and other medical therapies to treat chronic coronary disease.
June 27, 2023
In this video, surgeons demonstrate a Vouhe procedure on a patient with anomalous left coronary artery origin from the right coronary sinus.
June 6, 2023
This video showcases a successful posterior postinfarction ventricular septal defect closure parachuting two composite handmade patches through the aortic valve and the tricuspid valve—without performing a left ventriculotomy.
March 20, 2023
In this video, using a simulator, the authors show how to deal with a graft flattening and kinking at the anastomotic site—a common error in diamond-shaped sequential anastomoses.
October 13, 2022
The CSP 474 trial challenges some of the conventional knowledge around graft choice in CABG surgery, as was presented at the European Association for Cardiothoracic Surgery (EACTS) conference.
August 19, 2022
A new analysis by a team led by Dr. Mario Gaudino of Weill Cornell Medicine and NewYork-Presbyterian shows that a combination of two antiplatelets drugs can benefit patients after coronary artery bypass graft surgery but also increases the risk of potentially dangerous bleeding.
June 23, 2022
This scientific statement is a granular contribution to a major cardiovascular issue, illuminating nuances of the "generally recognized as safe" (GRAS) FDA designation. One would expect the relevant Thoracic Associations in North America and Europe to contribute to this debate.